+ Filter
Loading...
CD19 & CD47
Loading...Anti-CD19 & CD47 Products
- anti-CD19 immunotoxin HD37 (scFv)-PE (AGTO-L047E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-Human CD19 Recombinant Antibody (TAB-108CL) (TAB-108CL)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Antibody
- Application: FC, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1611CL-F(E)) (TAB-1611CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: Depletion, FuncS
- Human Anti-CD47 Recombinant Antibody (TAB-303LC) (TAB-303LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Anti-Human CD19 Recombinant Antibody scFv Fragment (HD37) (TAB-1620CL-S(P))
-
- Application: FuncS
- Mouse Anti-CD19 Recombinant Antibody (TAB-1611CL) (TAB-1611CL)
-
- Species Reactivity: Human
- Type: Mouse IgG2a, κ
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1612CL) (TAB-1612CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1613CL) (TAB-1613CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1
- Application: Cyt, FC, FuncS, Inhib
- Human Anti-CD19 Recombinant Antibody (TAB-1614CL) (TAB-1614CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1616CL) (TAB-1616CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody (TAB-1617CL) (TAB-1617CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody (TAB-1618CL) (TAB-1618CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody (TAB-1619CL) (TAB-1619CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: scFv fragment
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, FC, ICC, IF, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: WB, FC, IHC, IP, FuncS
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, IP, Neut, FuncS, ELISA, FC, WB
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Anti-Human CD19 Recombinant Antibody scFv Fragment (cHD37) (TAB-1621CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: FuncS
- Anti-Human CD19 Recombinant Antibody (cHD37) (TAB-1621CL)
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1613CL-S(P)) (TAB-1613CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1614CL-S(P)) (TAB-1614CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1616CL-S(P)) (TAB-1616CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1617CL-S(P)) (TAB-1617CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1618CL-S(P)) (TAB-1618CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1619CL-S(P)) (TAB-1619CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1612CL-F(E)) (TAB-1612CL-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1613CL-F(E)) (TAB-1613CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1614CL-F(E)) (TAB-1614CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1616CL-F(E)) (TAB-1616CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1617CL-F(E)) (TAB-1617CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1618CL-F(E)) (TAB-1618CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1619CL-F(E)) (TAB-1619CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody Fab Fragment (TAB-1626CL-F(E)) (TAB-1626CL-F(E))
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD19 Recombinant Antibody Fab Fragment (TAB-1627CL-F(E)) (TAB-1627CL-F(E))
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD47 Recombinant Antibody (TAB-278LC) (TAB-278LC)
-
- Species Reactivity: Human
- Type: Human IgG, κ
- Application: Block, FuncS
- Human Anti-CD47 Recombinant Antibody (TAB-279LC) (TAB-279LC)
-
- Species Reactivity: Human
- Type: Human IgG, κ
- Application: Block, FuncS
- Human Anti-CD47 Recombinant Antibody (TAB-280LC) (TAB-280LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-284LC) (TAB-284LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-285LC) (TAB-285LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-286LC) (TAB-286LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-287LC) (TAB-287LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-288LC) (TAB-288LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-289LC) (TAB-289LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-290LC) (TAB-290LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-291LC) (TAB-291LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-292LC) (TAB-292LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-293LC) (TAB-293LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-294LC) (TAB-294LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-295LC) (TAB-295LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-296LC) (TAB-296LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-297LC) (TAB-297LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-298LC) (TAB-298LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-299LC) (TAB-299LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-300LC) (TAB-300LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-301LC) (TAB-301LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-302LC) (TAB-302LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-278LC-S(P)) (TAB-278LC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-279LC-S(P)) (TAB-279LC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-280LC-S(P)) (TAB-280LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-281LC-S(P)) (TAB-281LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1612CL-S(P)) (TAB-1612CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Depletion, FuncS
- Anti-Human CD19 Recombinant Antibody scFv Fragment (396) (TAB-1625CL-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: Depletion, ELISA
- Human Anti-CD19 Recombinant Antibody scFv Fragment (TAB-1626CL-S(P)) (TAB-1626CL-S(P))
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD19 Recombinant Antibody scFv Fragment (TAB-1627CL-S(P)) (TAB-1627CL-S(P))
-
- Type: Fully human antibody
- Application: Depletion
- Anti-Human CD19 Recombinant Antibody Fab Fragment (HD37) (TAB-1620CL-F(E))
-
- Application: FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1622CL-S(P)) (TAB-1622CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1623CL-S(P)) (TAB-1623CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody scFv Fragment (381) (TAB-1624CL-S(P))
-
- Application: FC, Inhib, ELISA
- Anti-CD19 immunotoxin HD37 (IgG)-PE (AGTO-G076E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-DT (AGTO-G076D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-RTA (AGTO-G076R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-Sap (AGTO-G076S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-PAP (AGTO-G076P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-DT (AGTO-L047D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD19 immunotoxin HD37 (scFv)-RTA (AGTO-L047R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD19 immunotoxin HD37 (scFv)-Sap (AGTO-L047S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD19 immunotoxin HD37 (scFv)-PAP (AGTO-L047P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
- Mouse Anti-CD19 Recombinant Antibody (TAB-1622CL) (TAB-1622CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody (TAB-1623CL) (TAB-1623CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody (381) (TAB-1624CL)
-
- Application: FC, Inhib, ELISA
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1611CL-S(P)) (TAB-1611CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
- Anti-Human CD19 Recombinant Antibody (HD37) (TAB-1620CL)
-
- Application: FuncS
-
- Targets: CD19 & CD47
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
- Anti-CD19 (clone hBU12)-vcPAB-MMAE ADC (ADC-150CL)
-
- Target: CD19
- Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (clone BU12)-MC-MMAF ADC (ADC-189CL)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (hBU12)-mcMMAF ADC (ADC-017LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (hBU12)-Mc-MMAE ADC (ADC-019LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (huB4)-SPDB-DM4 ADC (ADC-020LCT)
-
- Target: CD19
- Linker: SPDB (N-succinimidyl 4-(2-pyridyldithio)butyrate)
- Drug: DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
- Anti-CD19 (clone huB4)-mc-MMAF ADC (ADC-045LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-CD19 (clone B496)-SPP-DM1 ADC (ADC-181LZY)
-
- Target: CD19
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (Denintuzumab)-Mc-MMAF ADC (ADC-175LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (clone B496)-MCC-DM1 ADC (ADC-182LZY)
-
- Target: CD19
- Linker: MCC (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone B496)-mc-vc-PABC-MMAE ADC (ADC-183LZY)
-
- Target: CD19
- Linker: mc-VC-PABC (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD19 (clone huB4)-SMCC-DM1 ADC (ADC-157LZY)
-
- Target: CD19
- Linker: SMCC (4-[N-maleimidomethyl] cyclohexane-1 carboxylhydrazide).
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone B496)-mc-MMAF ADC (ADC-184LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-CD19 (clone MDX1435)-vc-duocarmycin ADC (ADC-163LZY)
-
- Target: CD19
- Linker: VC (valine-citrulline)
- Drug: duocarmycin
- Anti-CD19 (hBU12)-Mc-MMAF ADC (SGN-19A) (ADC-L034)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
This gene encodes a membrane protein, which is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix. The encoded protein is also a receptor for the C-terminal cell binding domain of thrombospondin, and it may play a role in membrane transport and signal transduction. This gene has broad tissue distribution, and is reduced in expression on Rh erythrocytes.


Primary Immunodeficiency
